This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Bicyclic Peptide Ligands. Top assignees: Bicyclerd Limited, Bicycletx Limited. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridgeshire, GB (2018)
- Cambridge, GB (2018 - 2024)
Company Filing History:
Years Active: 2018-2026
Areas of Expertise:
Title: Catherine Lucy Stace: Innovator in Peptide Ligand Technology
Introduction
Catherine Lucy Stace is a distinguished inventor based in Cambridge, United Kingdom. With an impressive portfolio of 13 patents, Stace has made significant contributions to the field of biotechnology, particularly in the development of peptide ligands that have promising applications in healthcare.
Latest Patents
Among her latest innovations are two notable patents: "Modulation of Structured Polypeptide Specificity," which describes peptide ligands that are specifically targeted towards human plasma Kallikrein, and "Bicyclic Peptide Ligands Specific for MT1-MMP," which relates to polypeptides covalently bound to molecular scaffolds. These polypeptides, with their unique structure, enhance the specificity and affinity for membrane type 1 metalloprotease (MT1-MMP). Furthermore, this invention also encompasses drug conjugates that incorporate these peptides, aimed at improving imaging and targeted cancer therapies.
Career Highlights
Catherine Stace has cultivated her expertise in the biotechnology sector through her role at Bicyclerd Limited, a company focused on groundbreaking developments in peptide technologies. Her innovative work has positioned her as a leading figure in her field, aiming to leverage peptide ligands for enhancing therapeutic outcomes.
Collaborations
Stace has been known to collaborate with esteemed colleagues such as Edward Walker and Daniel Paul Teufel. Together, they have created a synergistic environment that fosters innovative ideas and approaches, contributing to the ongoing development of peptide-based therapies.
Conclusion
Catherine Lucy Stace's contributions to the field of peptide ligands exemplify the spirit of innovation and dedication to advancing medical technology. With her numerous patents and collaborative efforts, Stace continues to pave the way for future discoveries that hold the potential to transform cancer therapy and other medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile